YMAB
Y-mAbs Therapeutics
YMAB
YMAB
Delisted
YMAB was delisted on the 15th of September, 2025.
80 hedge funds and large institutions have $523M invested in Y-mAbs Therapeutics in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 31 increasing their positions, 30 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
14% less capital invested
Capital invested by funds: $606M → $523M (-$83.8M)
Holders
80
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$14.3M | |
| 2 | +$7.51M | |
| 3 | +$4.22M | |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
+$3.55M |
| 5 |
Aviva
London,
United Kingdom
|
+$3.46M |
Top Sellers
| 1 | -$6.39M | |
| 2 | -$6.31M | |
| 3 | -$4.33M | |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$3.54M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.78M |